Sumatriptan succinate and Pulmonary mass - a phase IV clinical study of FDA data

Summary:

Pulmonary mass is reported as a side effect among people who take Sumatriptan succinate (sumatriptan succinate), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Zofran, and have Narcolepsy.

The phase IV clinical study analyzes which people have Pulmonary mass when taking Sumatriptan succinate. It is created by eHealthMe based on reports of 9,380 people who have side effects when taking Sumatriptan succinate from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Pulmonary mass?

Pulmonary mass is found to be associated with 1,135 drugs and 921 conditions by eHealthMe. Check the latest studies of Pulmonary mass.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

9,380 people reported to have side effects when taking Sumatriptan succinate.
Among them, 17 people (0.18%) have Pulmonary mass.

Could Sumatriptan succinate cause Pulmonary mass?

Among these 17 people:

How long have people been on Sumatriptan succinate when they have Pulmonary mass? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pulmonary mass when taking Sumatriptan succinate? *

  • female: 86.67 %
  • male: 13.33 %

What is the age of people who have Pulmonary mass when taking Sumatriptan succinate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 11.11 %
  • 60+: 88.89 %

What are other drugs people take besides Sumatriptan succinate? *

  1. Zofran: 5 people, 29.41%
  2. Promethazine: 4 people, 23.53%
  3. Xyrem: 4 people, 23.53%
  4. Adderall: 4 people, 23.53%
  5. Calcium: 4 people, 23.53%
  6. Epipen: 4 people, 23.53%
  7. Prednisone: 4 people, 23.53%
  8. Zyrtec: 3 people, 17.65%
  9. Maxalt: 3 people, 17.65%
  10. Melatonin: 3 people, 17.65%

What are other side effects people have besides Pulmonary mass? *

  1. Fatigue (feeling of tiredness): 5 people, 29.41%
  2. Pneumonia: 5 people, 29.41%
  3. Weight Decreased: 4 people, 23.53%
  4. Abdominal Pain Upper: 4 people, 23.53%
  5. Fall: 4 people, 23.53%
  6. Rib Fracture: 4 people, 23.53%
  7. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 17.65%
  8. Nausea (feeling of having an urge to vomit): 3 people, 17.65%
  9. Dehydration (dryness resulting from the removal of water): 3 people, 17.65%
  10. Memory Loss: 3 people, 17.65%

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 23.53%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 17.65%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 17.65%
  4. Hereditary Angioedema (recurrent episodes of severe swelling): 2 people, 11.76%
  5. Thyroid Cancer: 2 people, 11.76%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.76%
  7. Pain: 1 person, 5.88%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%
  10. Cluster Headache (one-sided head pain with tearing): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and have Pulmonary mass?

- Check whether Pulmonary mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumatriptan succinate:

Pulmonary mass treatments and more:

How severe was Pulmonary mass and when was it recovered:

Expand to all the drugs that have ingredients of sumatriptan succinate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary mass:

Browse all the conditions that are associated with Pulmonary mass:


How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan succinate) and Sumatriptan succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: